1 - 25 of
280
results
for author:"Kato Y."
in Literature Citations
| Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction. Kimura H., Kato Y., Shimizu S., Takano K., Sato K. Thyroid 19:975-981(2009) · Mapped (8) |
| MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., Kato Y., Sato T., Lotz M.K., Asahara H. Arthritis Rheum. 60:2723-2730(2009) · Mapped (3) |
| Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. Xiao W., Hong H., Kawakami Y., Kato Y., Wu D., Yasudo H., Kimura A., Kubagawa H., Bertoli L.F., Davis R.S. et al. Cancer Cell 16:161-171(2009) · Mapped (27) |
| PROP1 coexists with SOX2 and induces PIT1-commitment cells. Yoshida S., Kato T., Susa T., Cai L.Y., Nakayama M., Kato Y. Biochem. Biophys. Res. Commun. 385:11-15(2009) · Mapped (2) |
| Embryonic lethality of fortilin-null mutant mice by BMP-pathway overactivation. Koide Y., Kiyota T., Tonganunt M., Pinkaew D., Liu Z., Kato Y., Hutadilok-Towatana N., Phongdara A., Fujise K. Biochim. Biophys. Acta 1790:326-338(2009) · Mapped (1) |
| Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice. Jiang F., Yoshida T., Nakaki F., Terawaki S., Chikuma S., Kato Y., Okazaki I.M., Honjo T., Okazaki T. Int. Immunol. 21:499-509(2009) · Mapped (2) |
| AAA+ Ring and linker swing mechanism in the dynein motor. Roberts A.J., Numata N., Walker M.L., Kato Y.S., Malkova B., Kon T., Ohkura R., Arisaka F., Knight P.J., Sutoh K. et al. Cell 136:485-495(2009) · Mapped (1) |
| Identification of the Drosophila Mes4 gene as a novel target of the transcription factor DREF. Suyari O., Ida H., Yoshioka Y., Kato Y., Hashimoto R., Yamaguchi M. Exp. Cell Res. 315:1403-1414(2009) · Mapped (14) |
| Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels. Ishimura E., Okuno S., Kono K., Fujino-Kato Y., Maeno Y., Kagitani S., Tsuboniwa N., Nagasue K., Maekawa K., Yamakawa T. et al. Diabetes Res. Clin. Pract. 83:320-326(2009) · Mapped (13) |
| Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes. Liu K.X., Kato Y., Matsumoto K., Nakamura T., Kaku T., Sugiyama Y. Pharm. Res. 26:1012-1021(2009) · Mapped (3) |
| Expression of inducible nitric oxide synthase and nitric oxide-modified proteins in Helicobacter pylori-associated atrophic gastric mucosa. Naito Y., Takagi T., Okada H., Nukigi Y., Uchiyama K., Kuroda M., Handa O., Kokura S., Yagi N., Kato Y. et al. J. Gastroenterol. Hepatol. 23 Suppl 2:S250-7(2008) · Mapped (3) |
| Efficacy of activated lymphocytes transfer therapy as a novel maker for serum granulysin level with advanced gastric cancer patients. Kato Y., Cyon J.C., Yoshimatsu K., Ogawa K. Gan To Kagaku Ryoho 35:2262-2264(2008) · Mapped (3) |
| HSV type 1 thymidine kinase protein accumulation in round spermatids induces male infertility by spermatogenesis disruption and apoptotic loss of germ cells. Cai L.Y., Kato T., Nakayama M., Susa T., Murakami S., Izumi S., Kato Y. Reprod. Toxicol. 27:14-21(2009) · Mapped (2) |
| Liver X receptors (LXRalpha and LXRbeta) are potent regulators for hepatic Dec1 expression. Noshiro M., Usui E., Kawamoto T., Sato F., Nakashima A., Ueshima T., Honda K., Fujimoto K., Honma S., Honma K. et al. Genes Cells 14:29-40(2009) · Mapped (6) |
| Activation of TGF-beta/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts. Kon N., Hirota T., Kawamoto T., Kato Y., Tsubota T., Fukada Y. Nat. Cell Biol. 10:1463-1469(2008) · Mapped (6) |
| Highly boron deficiency-tolerant plants generated by enhanced expression of NIP5;1, a boric acid channel. Kato Y., Miwa K., Takano J., Wada M., Fujiwara T. Plant Cell Physiol. 50:58-66(2009) · Mapped (3) |
| A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome. Kotani K., Satoh N., Kato Y., Araki R., Koyama K., Okajima T., Tanabe M., Oishi M., Yamakage H., Yamada K. et al. Atherosclerosis 204:526-531(2009) · Mapped (2) |
| Cloning and characterization of porcine CArG binding factor A expression in the anterior pituitary. Takahashi J., Ishikawa A., Susa T., Kato T., Kato Y. J. Reprod. Dev. 54:424-430(2008) · UniProtKB (1) |
| Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2. Ogasawara S., Kaneko M.K., Price J.E., Kato Y. Hybridoma (Larchmt) 27:259-267(2008) · Mapped (3) |
| Gasdermin D (Gsdmd) is dispensable for mouse intestinal epithelium development. Fujii T., Tamura M., Tanaka S., Kato Y., Yamamoto H., Mizushina Y., Shiroishi T. Genesis 46:418-423(2008) · Mapped (1) |
| Characterization of rat beta-glucan receptor dectin-1. Kato Y., Adachi Y., Ohno N. Microbiol. Immunol. 52:418-428(2008) · UniProtKB (2) |
| Podocalyxin expression in malignant astrocytic tumors. Hayatsu N., Kaneko M.K., Mishima K., Nishikawa R., Matsutani M., Price J.E., Kato Y. Biochem. Biophys. Res. Commun. 374:394-398(2008) · Mapped (1) |
| Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart. Iwata D., Kato Y., Wakayama T., Sai Y., Kubo Y., Iseki S., Tsuji A. Drug Metab. Pharmacokinet. 23:207-215(2008) · Mapped (3) |
| Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Nakazawa Y., Sato S., Naito M., Kato Y., Mishima K., Arai H., Tsuruo T., Fujita N. Blood 112:1730-1739(2008) · Mapped (7) |
| Structural characterisation of PinA WW domain and a comparison with other group IV WW domains, Pin1 and Ess1. Ng C.A., Kato Y., Tanokura M., Brownlee R.T. Biochim. Biophys. Acta 1784:1208-1214(2008) · Mapped (1) |
